Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Cordlife Group ( (SG:P8A) ) just unveiled an update.
Cordlife Group Limited is currently under investigation by the Commercial Affairs Department for potential violations of the Securities and Futures Act 2001 of Singapore. The company’s CFO, Ms. Thet Hnin Yi, has recently participated in another interview with the authorities regarding these investigations. The Board and Nominating Committee are closely monitoring the investigation’s developments to reassess Ms. Thet’s position as CFO. Shareholders and potential investors are advised to exercise caution while dealing with the company’s shares.
More about Cordlife Group
Cordlife Group Limited is a Singapore-registered company operating in the healthcare industry, primarily offering cord blood banking services. The company focuses on providing families with safe and reliable options for storing umbilical cord blood and other related medical services.
YTD Price Performance: 4.39%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $30.86M
See more insights into P8A stock on TipRanks’ Stock Analysis page.
